March was marked by our Aventure de l’Innovation #22, this event was hosted by one of our historical LallianSe Experts, Olivier Favre-Bulle (CEO 3Biotech) : we would like to thank him for sharing his knowledge and experience so openly. No replay available, so feel free to reach out to us so that we can share some hints about this great event.
The award ceremony for the Challenge Innovation #2, which took place in February, was also an opportunity to highlight the partnership between LallianSe x the hospitals from APHP.Sorbonne Université, as well as Cécile Combes, winner of the Challenge Innovation, through our chronicle, Do you speak LallianSe, find here the episod #4.
And finally, we cannot look in the mirror for March without mentionning the 4th anniversary of the LallianSe LAB. 4 years of LallianSe LAB, four years of meetings, discussions, events, creation of projects, challenges, synergies, in short of community and amazing interactions. Thank you so much!
4 years of LallianSe LAB and a new adventure : with a new partnership with the HG APHP.Nord Université de Paris and the opening of the second LallianSe LAB at Bichat hospital in the north of Paris! The whole team is very excited of this new opening in 2021. A ‘journey notebook’ to share the project milestones and the birth of this new environment is under press… Stay tuned!
Hello April !
In April, join us for our Aventure de l’Innovation #23 which will be led by a tandem this time: Thierry Sarda, COO DTA Medical et Expert LallianSe & Christophe Vergne, fondateur et CEO MyPL. Meet on Tuesday, April 6th at 6.30pm, beware that this event is already full!
Finally, Pascale Maisonneuve,our partner and master in regulatory strategy will share our insights with our partner Médicalps :
– On Thursday, April 29th at 11am : “Médicament ou DM : Comment adapter ma stratégie réglementaire selon les nouvelles exigences européennes ? ” here is the link to register.